Real-time enrollment status for this hereditary malignant neoplasm clinical trial
Current Status
Recruiting
Checked: July 20, 2026 at 3:58 PM UTC
| NCT Number | NCT06927947 |
| Recruiting Status | Recruiting |
| Condition | Hereditary Malignant Neoplasm |
| Phase | NA |
| Target Enrollment | 625 participants |
| Active Locations | 1 sites in the US |
| Sponsor | University of Michigan Rogel Cancer Center |
| Last Updated on CT.gov | June 15, 2026 (Jun 15, 2026) |
As of July 20, 2026: Clinical trial NCT06927947 is currently recruiting participants. This na study for hereditary malignant neoplasm is actively seeking new participants at 1 location across the United States. The study is sponsored by University of Michigan Rogel Cancer Center. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06927947 is actively recruiting participants as of July 20, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06927947 was last updated Jun 15, 2026 (June 15, 2026). HelloStudys verifies this status automatically.